GlassScriptPhysician profile
Paul Hugh Benson
NPI 1558636639
$14,048.88
in general payments reported to CMS, 2019-2025
31 companies · $8,807 in 2025
The $8,807 reported for 2025 was more than what 93% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $988 · 2020: $705 · 2021: $31.22 · 2022: $1,137 · 2023: $603 · 2024: $1,778 · 2025: $8,807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,605 · Food and Beverage: $3,170 · Travel and Lodging: $2,413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,605.00 |
| Food and Beverage | $3,169.57 |
| Travel and Lodging | $2,412.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $8,261.61 | 2024-2025 | Cvac Aspiration System |
| Medtronic, INC. | $1,174.92 | 2022-2025 | Interstim |
| Intuitive Surgical, INC. | $988.19 | 2019 | |
| Axonics, INC. | $796.93 | 2022-2024 | Axonics, Bulkamid |
| Neotract INC. | $634.18 | 2020 | |
| Boston Scientific Corporation | $302.34 | 2022-2025 | Spaceoar Vue System - 10ml, Lithovue, Rezum Generator |
| Procept Biorobotics Corporation | $270.76 | 2024-2025 | Aquabeam System |
| Kerecis Limited | $224.03 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Sumitomo Pharma America, INC. | $204.89 | 2024 | Gemtesa |
| Urogen Pharma, INC. | $167.20 | 2023-2025 | Jelmyto |
| Olympus America INC. | $165.39 | 2024-2025 | Itind System |
| Janssen Biotech, INC. | $151.32 | 2023-2024 | Erleada, Akeega |
| Sun Pharmaceutical Industries INC. | $75.95 | 2022 | |
| Teleflex LLC | $74.86 | 2022-2025 | Barrigel |
| Medtronic USA, INC. | $52.61 | 2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $48.23 | 2024 | Prolaris |
| Valencia Technologies Corporation | $47.71 | 2025 | Ecoin Device Kit |
| Pfizer INC. | $46.42 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $45.25 | 2024 | |
| Tolmar, INC. | $36.01 | 2025 | Jatenzo, Eligard |
| Baxter Healthcare | $35.59 | 2022 | |
| Blue Earth Diagnostics | $35.46 | 2023-2024 | |
| Kowa Pharmaceuticals America, INC. | $34.35 | 2023 | Seglentis |
| Astellas Pharma US INC | $32.98 | 2022 | |
| Urovant Sciences INC | $24.51 | 2022 | |
| Avation Medical, INC. | $23.30 | 2024 | Vivally |
| Bayer Healthcare Pharmaceuticals INC. | $22.47 | 2022 | |
| Endo Pharmaceuticals INC. | $20.55 | 2022 | |
| Coloplast Corp | $19.56 | 2023 | Speedicath |
| Glaxosmithkline, LLC. | $18.47 | 2020 | |
| Abbvie INC. | $12.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Benson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.